Italia markets open in 6 hours 27 minutes

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
265,44+4,43 (+1,70%)
Alla chiusura: 04:00PM EDT
265,36 -0,08 (-0,03%)
Dopo ore: 06:11PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente261,01
Aperto262,10
Denaro265,40 x 800
Lettera265,44 x 1000
Min-Max giorno260,91 - 266,14
Intervallo di 52 settimane211,71 - 296,67
Volume2.526.076
Media Volume2.485.862
Capitalizzazione141,984B
Beta (5 anni mensile)0,61
Rapporto PE (ttm)17,90
EPS (ttm)14,83
Prossima data utili01 nov 2023 - 06 nov 2023
Rendimento e dividendo (futuro)8,52 (3,26%)
Data ex dividendo17 ago 2023
Stima target 1A264,74
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery